Marco Pugliese


Director de EIT Health Spain.

Born in Latina (Italy) in 1968. Bachelor in Veterinary in 1994 from the University of Perugia (Italy). PhD in Neuroscience from the University of Barcelona in 2005 with a research based on the characterization of cognitive dysfunction in companion dog and its usefulness as an alternative model of Alzheimer’s disease. In 2005, he won a research prize of the Royal Spanish Academy of Veterinary Science with a study based on the selective neurodegeneration in dog’s central nervous system (CNS). In 2006, he co-founded Neurotec Pharma with the aim to develop new treatments for CNS diseases mainly related with inflammation and neurodegeneration. From 2008 to 2014, he was CEO of the company. From July 2014 to September 2015 he has worked as Manager of Innovation and Technology Transfer at the Research Institute of Vall d’Hebron (VHIR). He is currently Director of the Spanish node of EIT Health. Dr Pugliese is co-inventor of 7 patents related to the development of treatment for CNS diseases and he is author of 22 international publications in the field of Neuroscience.

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

Aviso de cookies